通过白细胞表达谱理解急性呼吸窘迫综合征生物学表型的异质性
本研究在原有脓毒症相关ARDS患者队列中加入血白细胞转录组学和生物信息学分析,纳入两个ICU在1.5年期间收治的210例脓毒症合并ARDS患者,其中反应型128例、未炎症型82例。结果显示,11,443个转录本中有3,332个(29%)在两种表型间存在显著差异。经典通路分析显示,氧化磷酸化基因上调提示线粒体功能障碍(通路中52%的基因),未炎症型则以丝裂原活化蛋白激酶通路上调为特征。作者认为,约三分之一的基因在ARDS生物学表型间差异表达,支持ARDS亚组在病理生理上不可比,并提示聚焦氧化磷酸化的个体化干预可能至关重要。
要点
- 在210例脓毒症合并ARDS患者中,反应型128例、未炎症型82例,两种表型间29%(3,332/11,443)的白细胞转录本显著差异表达。
- 经典通路分析显示反应型表型氧化磷酸化基因上调,提示线粒体功能障碍,该通路中52%的基因上调。
- 未炎症型表型以丝裂原活化蛋白激酶通路上调为特征。
- 作者认为约三分之一的基因在ARDS生物学表型间差异表达,支持这些亚组在病理生理上不可比,并提示聚焦氧化磷酸化的个体化干预可能至关重要。
适用人群与场景
- 两个ICU在1.5年期间收治的脓毒症合并ARDS患者,共210例,其中反应型128例、未炎症型82例。
研究设计与关键结果
- 研究类型为在现有脓毒症相关ARDS患者队列中加入血白细胞转录组学和生物信息学分析的新研究,纳入两个ICU在1.5年期间收治的210例脓毒症合并ARDS患者。
- 反应型表型128例,未炎症型82例;11,443个转录本中有3,332个(29%)在两种表型间显著差异表达。
- 经典通路分析显示反应型表型氧化磷酸化基因上调,提示线粒体功能障碍,该通路中52%的基因上调;未炎症型表型以丝裂原活化蛋白激酶通路上调为特征。
证据类型、等级与局限
- 证据类型为在现有患者队列中加入血白细胞转录组学和生物信息学分析的研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,约三分之一的基因在ARDS生物学表型间差异表达,支持ARDS亚组在病理生理上不可比。
- 作者认为,这些数据进一步支持ARDS患者的生物学异质性,并提示聚焦氧化磷酸化的个体化干预可能至关重要。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Rationale: Two biologic phenotypes of acute respiratory distress syndrome (ARDS) have been identified based on plasma protein markers in four previous studies. Objectives: To determine if blood leukocyte gene expression is different between the "reactive" and "uninflamed" phenotype. Methods: This is a new study adding blood leukocyte transcriptomics and bioinformatics analysis to an existing patient cohort of ARDS in patients with sepsis admitted to two ICUs during a 1.5-year period. Canonical pathway analysis was performed. Measurements and Main Results: A total of 210 patients with sepsis and ARDS were included, of whom 128 had a reactive and 82 an uninflamed phenotype. A total of 3,332/11,443 (29%) transcripts were significantly different between the phenotypes. Canonical pathway analysis showed upregulation of oxidative phosphorylation genes indicative of mitochondrial dysfunction (52% of genes in pathway). The uninflamed phenotype was characterized by upregulation of mitogen-activated protein kinase pathways. Conclusions: A third of genes are differentially expressed between biologic phenotypes of ARDS supporting the observation that the subgroups of ARDS are incomparable in terms of pathophysiology. These data provide additional support for biologic heterogeneity in patients with ARDS and suggests that a personalized approach to intervention focusing on oxidative phosphorylation is pivotal in this condition.
参考来源
- Bos LDJ, Scicluna BP, Ong DSY, et al. Understanding Heterogeneity in Biologic Phenotypes of Acute Respiratory Distress Syndrome by Leukocyte Expression Profiles. Am J Respir Crit Care Med. 2019. PMID: 30645145. doi:10.1164/rccm.201809-1808OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。